The RNAi therapeutics roller coaster

Add to your list(s) Download to your calendar using vCal

• Mr Dirk Haussecker (Author of the RNAi Therapeutics blog)
• Wednesday 21 November 2012, 19:00-20:30
• Large Lecture Theater, Department of Plant Sciences, Downing Site.

If you have a question about this talk, please contact Thomas Irving.

Part of the Biotechnology lecture series

The discovery of RNAi interference gene suppression in humans opened up the prospect of creating a transformative new class of medicines similar in importance to small molecules and monoclonal antibodies. A decade on, amid steady scientific progress, RNAi therapeutics has gone from most-hyped to most-ridiculed technology before entering the current phase in which, for the first time, business expectations and scientific realities have begun to align.

In his talk, Dr Haussecker will be discussing the factors that have been driving the rapid swings in public/investor perceptions and will try to distill general lessons applicable to the development of other new biotechnology platforms. Although the jury is still out, the evidence, including well-received recent clinical trial results, point towards developing solutions to technical bottlenecks and building scientific credibility to be the most rewarding early-stage business development strategy.

Date: Wednesday 21st November Time: 7PM Location: Plant Sciences lecture theatre, Downing Site. [map: www.map.cam.ac.uk] Free for BioSoc members; 1 pound entry for non-members.

This talk is part of the Cambridge University Biological Society series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• CamTalks
• Cambridge University Biological Society
• Centre for Health Leadership and Enterprise
• Cool science seminars
• DS list 1
• Featured lists
• Featured talks
• Large Lecture Theater, Department of Plant Sciences, Downing Site
• Life Sciences
• Life Sciences
• Major Public Lectures in Cambridge
• MedSoc

Note that ex-directory lists are not shown.